Critical role of IκB kinase alpha in embryonic skin development and skin carcinogenesis

Histology and Histopathology

Volumn 24, Issue 2, 2009, Pages 265-271

  Zhu, Feng ^a   Park, Eunmi ^a   Liu, Bigang ^a   Xia, Xiaojun ^a   Fischer, Susan M ^a   Hu, Yinling ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Embryonic skin development; I B kinase alpha (IKK ); Nuclear factorkappaB(NF B); Skin carcinogenesis

Indexed keywords

CARCINOGEN; I KAPPA B ALPHA; INTERFERON REGULATORY FACTOR 6; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CANCER GENETICS; CANCER INHIBITION; CANCER INVASION; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; DEVELOPMENTAL BIOLOGY; DISEASE ACTIVITY; DISEASE COURSE; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS HYPERPLASIA; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENETIC SUSCEPTIBILITY; GROWTH REGULATION; HUMAN; KERATINOCYTE; METASTASIS; MUTATIONAL ANALYSIS; NONHUMAN; ORGANOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; ANIMAL; CELL TRANSFORMATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; SKIN; SKIN TUMOR; TRANSGENIC MOUSE;

MUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B KINASE; MICE; MICE, TRANSGENIC; NF-KAPPA B; SKIN; SKIN NEOPLASMS;

EID: 59149093518     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Aldaz C.M., Conti C.J., Larcher F., Trono D., Roop D.R., Chesner J., Whitehead T. and Slaga T.J. (1988). Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas. Cancer Res. 48, 3253-3257.
2. Balmain A. and Pragnell I.B. (1983). Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303, 72-74.
3. Bonneau D. and Longy M. (2000). Mutations of the human PTEN gene. Hum. Mutat. 16, 109-122.
4. Candi E., Terrinoni A., Rufini A., Chikh A., Lena A.M., Suzuki Y., Sayan B.S., Knight R.A. and Melin G. (2006). p63 is upstream of IKK alpha in epidermal development. J. Cell. Sci. 119, 4617-4622.
5. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V. and Karin M. (2001). IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107, 763-775.
6. Connelly M.A. and Marcu K.B. (1995). CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain. Cell. Mol. Biol. Res. 41, 537-549.
7. Dellambra E., Golisano O., Bondanza S., Siviero E., Lacal P., Molinari M., D'Atri S. and De Luca M. (2000). Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149, 1117-1130.
8. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E. and Karin M. (1997). A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548-554.
9. Ferguson A.T., Evron E., Umbricht C.B., Pandita T.K., Chan T.A., Hermeking H., Marks J.R., Lambers A.R., Futreal P.A., Stampfer M.R. and Sukumar S. (2000). High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. USA 97, 6049-6054.
10. Fischle W., Wang Y. and Allis C.D. (2003). Binary switches and modification cassettes in histone biology and beyond. Nature 425, 475-479.
11. Fuchs E. and Byrne C. (1994). The epidermis: rising to the surface. Curr. Opin. Genet. Dev. 4, 725-736.
12. Gasco M., Bell A.K., Heath V., Sullivan A., Smith P., Hiller L., Yulug I., Numico G., Merlano M., Farrell P.J., Tavassoli M., Gusterson B. and Crook T. (2002). Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity. Cancer Res. 62, 2072-2076.
13. Grisendi S., Bernardi R., Rossi M., Cheng K., Khandker L., Manova K. and Pandolfi P.P. (2005). Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437, 147-153.
14. Hennings H., Glick A.B., Lowry D.T., Krsmanovic L.S., Sly L.M. and Yuspa S.H. (1993). FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14, 2353-2358.
15. Herron B.J., Liddell R.A., Parker A., Grant S., Kinne J., Fisher J.K. and Siracusa L.D. (2005) A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice. Nat. Genet. 37, 1210-1212.
16. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R. and Karin M. (1999). Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316-320.
17. Hu Y., Baud V., Oga T., Kim K.I., Yoshida K. and Karin M. (2001). IKKα controls formation of the epidermis independently of NF-κB. Nature 410, 710-714.
18. Ingraham C.R., Kinoshita A., Kondo S., Yang B., Sajan S., Trout K.J., Malik M.I., Dunnwald M., Goudy S.L., Lovett M., Murray J.C. and Schutte B.C. (2006). Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat. Genet. 38, 1335-1340.
19. Item C.B., Turhani D., Thurnher D., Sinko K., Yerit K., Galev K., Wittwer G., Lanre Adeyemo W., Klemens F., Ewers R. and Watzinger F. (2004). Gene symbol: IRF6. Disease: Van der Woude syndrome. Hum. Genet. 115, 175.
20. Jackson J.P., Lindroth A.M., Cao X. and Jacobsen S.E. (2002). Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416, 556-560.
21. Kemp C.J., Donehower L.A., Bradley A. and Balmain A. (1993). Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74, 813-822.
22. Koster M.I., Dai D., Marinari B., Sano Y., Costanzo A., Karin M. and Roop D.R. (2007). p63 induces key target genes required for epidermal morphogenesis. Proc. Natl. Acad. Sci. USA 104, 3255-3260.
23. Larcher F., Franco M., Bolontrade M., Rodriguez-Puebla M., Casanova L., Navarro M., Yancopoulos G., Jorcano J.L. and Conti C.J. (2003). Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol. Carcinog. 37, 83-90.
24. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., Chen T., Li E., Jenuwein T. and Peters A.H. (2003). Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr. Biol. 13, 1192-1200.
25. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C. and Verma I.M. (1999a). IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1322-1328.
26. Li Q., Van Antwerp D., Mercurio F., Lee K.F. and Verma I.M. (1999b). Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.
27. Li Q., Lu Q., Estepa G. and Verma I.M. (2005). Identification of 14-3-3{sigma} mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc. Natl. Acad. Sci. USA 102, 15977-15982.
28. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R. and Karin M. (1999). The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor kB activation and prevention of apoptosis. J. Exp. Med. 189, 1839-1845.
29. Liu B., Park E., Zhu F., Bustos T., Liu J., Shen J., Fischer S.M. and Hu Y. (2006). A critical role for I{kappa}B kinase {alpha} in the development of human and mouse squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 103, 17202-17207.
30. Maeda G., Chiba T., Kawashiri S., Satoh T. and Imai K. (2007). Epigenetic inactivation of IkappaB Kinase-alpha in oral carcinomas and tumor progression. Clin. Cancer Res. 13, 5041-5047.
31. Makris C., Godfrey V.L., Krahn-Senftleben G., Takahashi T., Roberts J.L., Schwarz T., Feng L., Johnson R.S. and Karin M. (2000). Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell 5, 969-979.
32. Mao J.H., To M.D., Perez-Losada J., Wu D., Del Rosario R. and Balmain A. (2004). Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev. 18, 1800-1805.
33. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S. and Ghosh S. (2000). Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289, 1550-1554.
34. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A. and Rao A. (1997). IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866.
35. Mock B.A., Connelly M.A., McBride O.W., Kozak C.A. and Marcu K.B. (1995). CHUK, a conserved helix-loop-helix ubiquitous kinase, maps to human chromosome 10 and mouse chromosome 19. Genomics 27, 348-351.
36. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E. and Fukasawa K. (2000). Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103, 127-140.
37. Park E., Zhu F., Liu B., Xia X., Shen J., Bustos T., Fischer S.M. and Hu Y. (2007). Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res. 67, 9158-9168.
38. Petersen S., Rudolf J., Bockmuhl U., Gellert K., Wolf G., Dietel M. and Petersen I. (1998). Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung. Oncogene 17, 449-454.
39. Rice J.C., Briggs S.D., Ueberheide B., Barber C.M., Shabanowitz J., Hunt D.F., Shinkai Y. and Allis C.D. (2003). Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol. Cell 12, 1591-1598.
40. Rothwarf D.M., Zandi E., Natoli G. and Karin M. (1998). IKK-gamma is an essential regulatory subunit of the IkB kinase complex. Nature 395, 297-300.
41. Saleem M., Afaq F., Adhami V.M. and Mukhtar H. (2004). Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 23, 5203-5214..
42. Scapoli L., Palmieri A., Martinelli M., Pezzetti F., Carinci P., Tognon M. and Carinci F. (2005). Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am. J. Hum. Genet. 76, 180-183.
43. Sil A.K., Maeda S., Sano Y., Roop D.R. and Karin M. (2004). IKKα acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428, 660-664.
44. Stewart M.D., Li J. and Wong J. (2005). Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment. Mol. Cell. Biol. 25, 2525-2538.
45. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N. and Akira S. (1999). Limb and skin abnormalities in mice lacking IKKα. Science 284, 313-316.
46. Tamaru H., Zhang X., McMillen D., Singh P.B., Nakayama J., Grewal S.I., Allis C.D., Cheng X. and Selker E.U. (2003). Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34, 75-79.
47. Van Waes C., Yu M., Nottingham L. and Karin M. (2007). Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma. Clin. Cancer Res. 13, 4956-4959.
48. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J. and Israel A. (1998). Complementation cloning of NEMO, a component of the IkB kinase complex essential for NF-κB activation. Cell 93, 1231-1240.
49. Zandi E., Chen Y. and Karin M. (1998). Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 281, 1360-1363.
50. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M. and Karin M. (1997). The IkB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IkB phosphorylation and NF-κB activation. Cell 91, 243-252.
51. Zhu F., Xia X., Liu B., Shen J., Hu Y., Person M. and Hu Y. (2007). IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing. Mol. Cell 27, 214-227.